Enzo: Quietly profitable

Enzo Biochem Inc. has been one of the mystery companies of biotech, seemingly hitting the radar screen only for earnings reports and patent litigation. In a recent conversation with BioCentury, the company presented a more rounded picture of its structure and strategy.

ENZ is organized as three independent subsidiaries: diagnostics, therapeutics and a clinical laboratory. Each has its own strategy, under a holding company. The diagnostics division was the basis for the formation of ENZ in 1976. While other companies were focusing on DNA as a manufacturing tool in the 1970s, ENZ was focused on recombinant DNA as an informational tool, said Barry Weiner, executive vice president...